Publications (27 results)
Please use discretion when following external links; Assaypro cannot guarantee the validity and security of all citation links provided.A comprehensive model for assessment of liver stage therapies targeting Plasmodium vivax and Plasmodium falciparum
- https://www.nature.com/articles/s41467-018-04221-9
- A Roth, SP Maher, AJ Conway, R Ubalee… - Nature …, 2018 - nature.com
- Malaria liver stages represent an ideal therapeutic target with a bottleneck in parasite load and reduced clinical symptoms; however, current in vitro pre-erythrocytic (PE) models for …
Selective Microvascular Tissue Transfection Using Minicircle DNA for Systemic Delivery of Human Coagulation Factor IX in a Rat Model Using a Therapeutic Flap
Endoscopic-mediated, biliary hydrodynamic injection mediating clinically relevant levels of gene delivery in pig liver
Plasma Proteome Analyses of Experimental Human and Murine Thyroid Disease Models
Systemic delivery of factor IX messenger RNA for protein replacement therapy
Therapeutic efficacy in a hemophilia B model using a biosynthetic mRNA liver depot system
Lipid formulations for delivery of messenger rna
Development of an efficient human hepatocyte culture platform for assessing novel therapeutic efficacy against Plasmodium liver parasites
Mrna therapeutic compositions and use to treat diseases and disorders
Lipidic nanoparticles for mrna delivering
Early detection of malignant pleural mesothelioma in asbestos-exposed individuals with a noninvasive proteomics-based surveillance tool
Lipid nanoparticle compositions and methods for mrna delivery
Long-Acting Coagulation Factors and Methods of Producing Same
Sex hormones affect the production of recombinant Factor IX in CHO and HEK-293 cell lines
* Than PA et al. (2022) Selective Microvascular Tissue Transfection Using Minicircle DNA for Systemic Delivery of Human Coagulation Factor IX in a Rat Model Using a Therapeutic Flap. Plast Reconstr Surg. 149(1):117-129
* Kruse RL (2021) Endoscopic-mediated, biliary hydrodynamic injection mediating clinically relevant levels of gene delivery in pig liver. Gastrointest Endosc. S0016-5107(21)01463-2.
* Engelmann B (2018) Plasma Proteome Analyses of Experimental Human and Murine Thyroid Disease Models. Ernst Moritz Arndt University of Greifswald. Dessertation.
* Ramaswamya S et al. (2017) Systemic delivery of factor IX messenger RNA for protein replacement therapy. Proc Natl Acad Sci USA. 114(10):E1941-E1950.
* DeRosa F et al. (2016) Therapeutic efficacy in a hemophilia B model using a biosynthetic mRNA liver depot system. Gene Therapy 23:699-
* Heartlein M et al. (2015) Lipid formulations for delivery of messenger rna. Patents: US 20150140070 A1.
* Maher SP (2014) Development of an efficient human hepatocyte culture platform for assessing novel therapeutic efficacy against Plasmodium liver parasites. University of South Florida. Graduate Theses and Dissertations.
* Heartlein M (2014) Mrna therapeutic compositions and use to treat diseases and disorders. Patent application:WO2014152940 A1
* Derosa F et al.(2014) Lipidic nanoparticles for mrna delivering. Patent application:WO2014089486 A1
* Ostroff RM et al. (2012) Early detection of malignant pleural mesothelioma in asbestos-exposed individuals with a noninvasive proteomics-based surveillance tool. PLoS One. 7(10):e46091
* Guild BC et al. (2012) Lipid nanoparticle compositions and methods for mrna delivery. Patent Application WO2012170930 A1
* Fima UE et al. (2010) Long-Acting Coagulation Factors and Methods of Producing Same. Patent No: US 8476234 B2
* Dadehbeigi N et al. (2008) Sex hormones affect the production of recombinant Factor IX in CHO and HEK-293 cell lines. Biotechnol Lett. 30(11):1909-12